G

GemPharmatech Co Ltd
SSE:688046

Watchlist Manager
GemPharmatech Co Ltd
SSE:688046
Watchlist
Price: 13.53 CNY -1.24% Market Closed
Market Cap: 5.5B CNY
Have any thoughts about
GemPharmatech Co Ltd?
Write Note

GemPharmatech Co Ltd
Retained Earnings

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

GemPharmatech Co Ltd
Retained Earnings Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
G
GemPharmatech Co Ltd
SSE:688046
Retained Earnings
ÂĄ455.4m
CAGR 3-Years
168%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Retained Earnings
ÂĄ28.2B
CAGR 3-Years
37%
CAGR 5-Years
37%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Retained Earnings
ÂĄ6.6B
CAGR 3-Years
31%
CAGR 5-Years
50%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Retained Earnings
ÂĄ19.1B
CAGR 3-Years
44%
CAGR 5-Years
59%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Retained Earnings
ÂĄ9.2B
CAGR 3-Years
23%
CAGR 5-Years
45%
CAGR 10-Years
44%
W
WuXi XDC Cayman Inc
HKEX:2268
Retained Earnings
ÂĄ562.5m
CAGR 3-Years
15%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

GemPharmatech Co Ltd
Glance View

Market Cap
5.5B CNY
Industry
Life Sciences Tools & Services

GemPharmatech Co., Ltd. engages in research and development, manufacture, and sale of experimental mouse models. The company is headquartered in Nanjing, Jiangsu and currently employs 1,342 full-time employees. The company went IPO on 2022-04-25. The firm uses gene-editing and other technologies to produce mouse models. The firm also involves in the business of customized model breeding, drug efficacy analysis, and model customization. The Company’s products are mainly used to satisfy the experimental demands in the fields of gene function cognition, disease mechanisms analysis, drug target discovery, and other fundamental researches.

Intrinsic Value
21.04 CNY
Undervaluation 36%
Intrinsic Value
Price
G

See Also

What is GemPharmatech Co Ltd's Retained Earnings?
Retained Earnings
455.4m CNY

Based on the financial report for Dec 31, 2023, GemPharmatech Co Ltd's Retained Earnings amounts to 455.4m CNY.

What is GemPharmatech Co Ltd's Retained Earnings growth rate?
Retained Earnings CAGR 3Y
168%

Over the last year, the Retained Earnings growth was 45%. The average annual Retained Earnings growth rates for GemPharmatech Co Ltd have been 168% over the past three years .

Back to Top